Joe Beggs delivers pitch at the BioHealth Capital Region Investment Conference in Rockville, MD
GenAssist participated in the prestigious Crab Trap Pitch Competition, showcasing its innovative muscle regeneration technology to leading investors and industry experts in the biohealth sector.
Read More
One of Ten innovative life sciences and healthtech companies chosen for 16-week accelerator
GenAssist was selected as one of ten innovative companies for Activation Capital's inaugural Frontier BioHealth Program, a comprehensive 16-week accelerator designed to advance life sciences and healthtech startups.
Read More
Gabe Haas delivers pitch to a room full of investors, strategic partners, and St. Louis ecosystem leaders
Following completion of the 14-week SLU New Venture Accelerator program, GenAssist presented at Demo Day, showcasing the company's progress to investors, strategic partners, and community leaders in the St. Louis entrepreneurial ecosystem.
Read More
Team completes an additional 100+ customer interviews, bringing the total to over 200
GenAssist successfully completed its second round of the National I-Corps Program, conducting over 100 additional customer discovery interviews and bringing the company's total customer interviews to over 200, further validating market fit and product-market alignment.
Read More
Includes an equity-free investment of up to $50,000
As part of the SLU New Venture Accelerator's first-ever cohort, GenAssist will have access to high-level business coaching from the Chaifetz Center for Entrepreneurship. This 14-week program will focus on customer discovery, validation, business development, revenue modeling, and more. The program will culminate with a Demo Day where GenAssist will pitch to and meet with investors, strategic partners, and other community leaders.
Read More
Won a $20,000 of in-kind services from Hologic
In March 2024, the GenAssist Team traveled to Lowell, MA, and pitched MyoGel for its applications in Women's health in front of a crowd of at least 200 people. GenAssist was awarded $20,000 worth of in-kind services from Hologic, a leading company in Women's health.
Read More
Recognition of Innovation and Uniqueness Protects Core Technology
GenAssist's core technology has been officially recognized and protected by the USPTO, securing the company's intellectual property and competitive advantage in the muscle regeneration market.
Read More
R&D funding accelerates the translation of results to impact
GenAssist received a $295K Phase I SBIR grant from the National Science Foundation to advance research and development of MyoMatrix technology for muscle regeneration applications.
Read More